Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences

Introduction

Grief is a common response to bereavement that for a minority of people becomes prolonged and impairing, increasing risk for physical and mental health problems including depression, suicidality and higher mortality. Earlier research indicates about 10% of adults exposed to nonviolent bereavement develop prolonged grief disorder (PGD), with substantially higher rates following unnatural losses; the COVID-19 pandemic has further amplified concern about grief-related morbidity. Available treatments such as Prolonged Grief Disorder Therapy (PGDT) produce statistically significant but modest effects and require lengthy, manualised programmes, and pharmacological options have shown limited efficacy. This study set out to examine whether psychedelic experiences following bereavement are associated with changes in grief symptoms, and whether two acute-trip attributes — emotional breakthroughs (intense overcoming of difficult feelings) and challenging experiences (acute unpleasant cognitive, emotional or physiological reactions) — relate to symptom change. Low and colleagues surveyed recreational psychedelic users who recalled a psychedelic episode after bereavement, predicting overall reductions in grief severity and that emotional breakthroughs would predict larger improvements while challenging experiences would predict smaller improvements or worsening of grief symptoms.